Substance
ID:1172
Names and Identifiers
Brand Name
EposerinCefizox in plastic containerCefizoxCeftixEpocelin
Synonyms
Ceftizoximum [inn-latin]Ceftizoxima [inn-spanish]Ceftizoxime
IUPAC name
(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
IUPAC Traditional name
ceftizoxime
Properties
No Data Available
Click here to submit data
Molecule Details
Drug Groups
approved
Description
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. [PubChem]
Indication
For the treatment of infections due to susceptible strains of microorganisms.
Pharmacology
Ceftizoxime is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Affected Organisms
Enteric bacteria and other eubacteria
Biotransformation
Ceftizoxime is not metabolized, and is excreted virtually unchanged by the kidneys in 24 hours.
Protein Binding
30% protein bound
Elimination
Ceftizoxime is not metabolized, and is excreted virtually unchanged by the kidneys in 24 hours.
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data